These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 15019163)

  • 41. [P53 in atherosclerotic plaques].
    Yang HP
    Zhonghua Yi Xue Za Zhi; 1993 Nov; 73(11):674-6, 702. PubMed ID: 8124617
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of gene expression profiles in primary and immortalized human pterygium fibroblast cells.
    Hou A; Voorhoeve PM; Lan W; Tin M; Tong L
    Exp Cell Res; 2013 Nov; 319(18):2781-9. PubMed ID: 24012806
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of survivin protein in pterygium and relationship with oxidative DNA damage.
    Maxia C; Perra MT; Demurtas P; Minerba L; Murtas D; Piras F; Corbu A; Gotuzzo DC; Cabrera RG; Ribatti D; Sirigu P
    J Cell Mol Med; 2008 Dec; 12(6A):2372-80. PubMed ID: 18266976
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A novel role for CRIM1 in the corneal response to UV and pterygium development.
    Maurizi E; Schiroli D; Atkinson SD; Mairs L; Courtney DG; O'Hagan B; McGilligan VE; Pagnamenta AT; Taylor JC; Vasquez JJD; Illanes-Velarde DE; Goldsmith D; Gouws P; Moore JE; Nesbit MA; Moore CBT
    Exp Eye Res; 2019 Feb; 179():75-92. PubMed ID: 30365943
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pterygium: histological and immunohistochemical aspects.
    Golu T; Mogoantă L; Streba CT; Pirici DN; Mălăescu D; Mateescu GO; Muţiu G
    Rom J Morphol Embryol; 2011; 52(1):153-8. PubMed ID: 21424047
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [LOH analysis for estimating genetic influences by space environments].
    Yatagai F; Morimoto S; Kato T; Honma M
    Biol Sci Space; 2002 Nov; 16(3):140. PubMed ID: 12695591
    [No Abstract]   [Full Text] [Related]  

  • 47. Mechanisms and biomarker candidates in pterygium development.
    Wanzeler ACV; Barbosa IAF; Duarte B; Borges D; Barbosa EB; Kamiji D; Huarachi DRG; Melo MB; Alves M
    Arq Bras Oftalmol; 2019; 82(6):528-536. PubMed ID: 31576927
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular Basis of Pterygium Development.
    Cárdenas-Cantú E; Zavala J; Valenzuela J; Valdez-García JE
    Semin Ophthalmol; 2016; 31(6):567-83. PubMed ID: 25415268
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transcriptome Analysis of Pterygium and Pinguecula Reveals Evidence of Genomic Instability Associated with Chronic Inflammation.
    Suarez MF; Echenique J; López JM; Medina E; Irós M; Serra HM; Fini ME
    Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769520
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The aetiology and pathology of pterygium.
    Elliott R
    Trans Ophthalmol Soc Aust; 1966; 25():71-4. PubMed ID: 5991946
    [No Abstract]   [Full Text] [Related]  

  • 51. Commentary: Expression of p53 and Ki-67 proteins in patients with increasing severity and duration of pterygium.
    Arora R
    Indian J Ophthalmol; 2021 Apr; 69(4):851. PubMed ID: 33727445
    [No Abstract]   [Full Text] [Related]  

  • 52. Comment on: Expression of p53 and Ki-67 proteins in patients with increasing severity and duration of pterygium.
    Dos Santos Martins TG
    Indian J Ophthalmol; 2021 Oct; 69(10):2887. PubMed ID: 34571668
    [No Abstract]   [Full Text] [Related]  

  • 53. Pterygium-The Good, the Bad, and the Ugly.
    Van Acker SI; Van den Bogerd B; Haagdorens M; Siozopoulou V; Ní Dhubhghaill S; Pintelon I; Koppen C
    Cells; 2021 Jun; 10(7):. PubMed ID: 34206333
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mapping the Spectrum of Gene Expression Responses.
    Pargett M; Albeck JG
    Cell Syst; 2016 Apr; 2(4):221-2. PubMed ID: 27135533
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pterygium as an early indicator of ultraviolet insolation: a hypothesis.
    Coroneo MT
    Br J Ophthalmol; 1993 Nov; 77(11):734-9. PubMed ID: 8280691
    [No Abstract]   [Full Text] [Related]  

  • 56. [On the genetic problems of corneal pterygium].
    Murken JD; Dannheim R
    Klin Monbl Augenheilkd; 1965 Nov; 147(4):574-9. PubMed ID: 5888370
    [No Abstract]   [Full Text] [Related]  

  • 57. Genomic instability and eye diseases.
    Liu H; Cheng J; Zhuang X; Qi B; Li F; Zhang B
    Adv Ophthalmol Pract Res; 2023; 3(3):103-111. PubMed ID: 37846358
    [TBL] [Abstract][Full Text] [Related]  

  • 58. State of the Art of Pharmacological Activators of p53 in Ocular Malignancies.
    Casciano F; Zauli E; Busin M; Caruso L; AlMesfer S; Al-Swailem S; Zauli G; Yu AC
    Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509256
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ocular surface squamous neoplasia in a patient following oral steroids for contralateral necrotising scleritis.
    Yin G; Gendler S; Teichman J
    BMJ Case Rep; 2022 Dec; 15(12):. PubMed ID: 36521875
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.